Cell Source Inc 's ROA from the first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Cell Source Inc 's ROA in the first quarter of 2025?
Due to the lack of assets, it was not possible to calculate Cell Source Inc 's return on assets (ROA) in its first quarter of 2025

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Total Assets Change	254.13 %	21.2 %	-26.95 %	84.89 %	-79.85 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-5	-5	-5	-5	-5
Return On Assets (TTM)	-1542.9 %	-1780.91 %	-2152.33 %	-1890.25 %	-2410.76 %
CLCS's Total Ranking	# 4952	# 5718	# 5103	# 5168	# 5251
Total Assets (TTM) in million	0	0	0	0	0
Seq. Total Assets Change	23.67 %	-10.65 %	-38.42 %	420.45 %	-57.68 %
Seq. Net Income Change	-	-	-	-	-

CLCS's 5 Years Annual ROA >> Back to CLCS Management Effectiveness >> Compare CLCS ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 496
Sector	# 1011
Overall	# 4874

Return On Assets Statistics
High	Average	Low
-535.02 %	-2089.44 %	-6756.22 %
(Sep 30 2018)		(Sep 30 2019)

Financial Statements
Cell Source Inc 's Assets	$ 0 million	CLCS's Balance sheet
Cell Source Inc 's Income	$ -1 million	Quarterly CLCS's Income Statement
CLCS's Income by Division		See CLCS's Income by Division

Annual Return On Assets	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020
Y / Y Total Assets Change	21.2 %	-52.4 %	30.63 %	-30.63 %	294.06 %
Total Assets in million	0	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-5	-5	-5	-5	-5
Annual Return On Assets	-1908.25 %	-2727.09 %	-1260.78 %	-1744.11 %	-1008.16 %

CLCS's 5 Years Annual ROA >> Back to CLCS Management Effectiveness >> Compare CLCS ROA to its Competitors

More Return On Assets Ratios
CLCS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CLCS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CLCS's Competitors
Subscribers only: Roa for Cell Source Inc 's Suppliers
Subscribers only: Return On Assets for CLCS's Customers

You may also want to know
CLCS's Roi	CLCS's Inventory Turnover Ratio	CLCS's Growth Rates	CLCS's Dividend Comparisons
	CLCS's Profitability Ratios	CLCS's Asset Turnover Ratio	CLCS's Dividend Growth
CLCS's Roe	CLCS's Valuation Ratios	CLCS's Financial Strength Ratios	CLCS's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2025, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:11:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.